关注
Khachen Kongpakwattana, Ph.D.
Khachen Kongpakwattana, Ph.D.
Lecturer, Faculty of Pharmaceutical Sciences, Chulalongkorn University
在 chula.ac.th 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
K Kengkla, K Kongpakwattana, S Saokaew, A Apisarnthanarak, ...
Journal of Antimicrobial Chemotherapy 73 (1), 22-32, 2018
1702018
A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant …
N Teerawattanapong, P Panich, D Kulpokin, SN Ranong, ...
infection control & hospital epidemiology 39 (5), 525-533, 2018
972018
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis
K Kongpakwattana, R Sawangjit, I Tawankanjanachot, JS Bell, SN Hilmer, ...
British journal of clinical pharmacology 84 (7), 1445-1456, 2018
742018
Global economic evaluations of rotavirus vaccines: A systematic review
S Kotirum, N Vutipongsatorn, K Kongpakwattana, R Hutubessy, ...
Vaccine 35 (26), 3364-3386, 2017
402017
A real-world evidence analysis of associations among costs, quality of life, and disease-severity indicators of Alzheimer’s disease in Thailand
K Kongpakwattana, C Dejthevaporn, O Krairit, P Dilokthornsakul, ...
Value in Health 22 (10), 1137-1145, 2019
262019
Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis
SS Ng, NM Lai, S Nathisuwan, NK Jahan, P Dilokthornsakul, ...
Scientific Reports 10 (1), 662, 2020
222020
Application of discrete-event simulation in health technology assessment: a cost-effectiveness analysis of Alzheimer’s disease treatment using real-world evidence in Thailand
K Kongpakwattana, N Chaiyakunapruk
Value in Health 23 (6), 710-718, 2020
162020
Cost-effectiveness analysis of non-statin lipid-modifying agents for secondary cardiovascular disease prevention among statin-treated patients in Thailand
K Kongpakwattana, Z Ademi, T Chaiyasothi, S Nathisuwan, E Zomer, ...
Pharmacoeconomics 37, 1277-1286, 2019
142019
Estimating the productivity burden of pediatric pneumococcal disease in Thailand
T Ounsirithupsakul, P Dilokthornsakul, K Kongpakwattana, Z Ademi, ...
Applied Health Economics and Health Policy 18, 579-587, 2020
82020
“From safe source to safe sink” development of colorimetric assay for gabapentin in bulk drug and capsules using naturally derived genipin
W Winotapun, K Kongpakwattana, S Dejpittayanunt, ...
Talanta 99, 997-1003, 2012
82012
Compliance and persistence with Alzheimer’s disease treatment: a retrospective analysis of multiregional hospital databases in Thailand
K Kongpakwattana, P Dilokthornsakul, C Dejthevaporn, O Pattanaprateep, ...
Journal of Medical Economics 22 (1), 26-34, 2019
62019
Compliance and persistence with Alzheimer’s disease treatment: a retrospective analysis of multiregional hospital databases in Thailand
K Kongpakwattana, P Dilokthornsakul, C Dejthevaporn, O Pattanaprateep, ...
Value in Health 21, S94, 2018
52018
Clinical and economic burden of postsurgical complications of high-risk surgeries: a cohort study in Thailand
K Kongpakwattana, P Dilokthornsakul, T Dhippayom, N Chaiyakunapruk
Journal of Medical Economics 23 (10), 1046-1052, 2020
42020
How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework?
C Limwongse, P Rojnuckarin, P Kupatawintu, A Thongthaisin, ...
Transfusion Medicine 33 (6), 497-502, 2023
12023
Implementing the Implementation Framework for Telemedicine to Address Non-Communicable Diseases in Thailand: What We Have Learned
MD Pairoj Chattranukulchai, MD Nuntakorn Thongtang, ...
J Med Assoc Thai 106 (1), 102-5, 2023
2023
Donepezil cost effective for Alzheimer’s disease in Thailand
K Kongpakwattana
PharmacoEconomics & Outcomes News 850, 17-4, 2020
2020
PIH22 ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND
T Ounsirithupsakul, N Chaiyakunapruk, P Dilokthornsakul, ...
Value in Health 22, S631, 2019
2019
ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND
T Ounsirithupsakul, N Chaiyakunapruk, P Dilokthornsakul, ...
VALUE IN HEALTH 22, S631-S631, 2019
2019
PCV62 ECONOMIC EVALUATION AND NETWORK META-ANALYSIS OF NON-STATIN THERAPY AMONG STATIN-TREATED PATIENTS IN THAILAND
K Kongpakwattana, Z Ademi, T Chaiyasothi, S Nathisuwan, E Zomer, ...
Value in Health 22, S552, 2019
2019
Direct medical costs are major driver of AD costs in Thailand
K Kongpakwattana
PharmacoEconomics & Outcomes News 835, 13-24, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20